Renalogic, a prominent healthcare solutions provider for self-funded plans dealing with chronic kidney disease (CKD), collaborated with Lyfebulb, an online patient empowerment platform, to conduct a survey aimed at gaining insights into the experiences and challenges faced by dialysis patients.
The survey revealed alarming statistics, with 62% of dialysis treatments being unplanned, highlighting the unpredictable nature of CKD. Additionally, over half of the patients had to cease working while undergoing dialysis, and 50% had experienced hospitalization or emergency room visits within the past year.
Kevin Weinstein, the CEO of Renalogic, emphasized the significant physical, emotional, and logistical hurdles that dialysis patients encounter in managing their condition. The partnership with Lyfebulb sought to amplify the voices of the patient community to drive meaningful improvements in the dialysis experience and clinical outcomes.
The comprehensive report resulting from the survey covers various critical aspects, including the financial implications of dialysis, the taxing effects on patients, barriers to accessing quality care and support services, and the impact on the workplace.
Karin Hehenberger, President of Lyfebulb, expressed gratitude for the collaboration with Renalogic, underscoring the importance of delving into the effects of dialysis on patients. While acknowledging the life-saving nature of dialysis, she emphasized the potential for further enhancements in care for individuals living with end-stage renal disease (ESRD).
Renalogic and Lyfebulb are dedicated to utilizing the survey findings to drive positive changes and improve the quality of life for the dialysis community. The Dialysis Patient Experience report, summarizing the insights, is accessible to the public.
Renalogic, established in 2002, specializes in assisting self-funded plans and their members in managing the human and financial burdens associated with CKD and dialysis treatment. Through cost-containment solutions and transparency measures, Renalogic aims to support plans in handling dialysis claims effectively and preventing disease progression.
